Exenatide therapy in insulin-treated type 2 diabetes and obesity.

Nayak, U A; Govindan, J; Baskar, V; Kalupahana, D; Singh, B M

Nayak, U A; Govindan, J; Baskar, V; Kalupahana, D; Singh, B M.

Affiliation

Nayak UA; Wolverhampton Diabetes Centre, New Cross Hospital, Wolverhampton, WV10 0QP, UK. ananth.nayak@nhs.net

QJM ; 103(9): 687-94, 2010 Sep.

Article in En | MEDLINE | ID: mdl-20624837

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Insulin/therapeutic use; Obesity/drug therapy; Peptides/therapeutic use; Venoms/therapeutic use; Aged; Body Weight/drug effects; Drug Therapy, Combination; Exenatide; Female; Humans; Male; Middle Aged; Prospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Venoms / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Insulin / Obesity Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: QJM Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google